Lawsuit Alleges Sam Waksal Administered Unapproved Veterinary Drug to Sick Child

A new lawsuit accuses biotech entrepreneur Sam Waksal of reckless conduct, specifically alleging he administered a veterinary medicine, unapproved for human use, to a severely ill child. The lawsuit details the accusations against Waksal, outlining the circumstances surrounding the alleged incident. The suit claims Waksal’s actions involved using a medication intended for animals on a child facing a severe illness. The medication in question had not received approval for human use from regulatory bodies. The legal action centers around Waksal’s alleged decision to administer the veterinary drug, prompting the “reckless conduct” accusation.

Newsflash | Powered by GeneOnline AI
Date: April 22, 2025

Related posts:

Breakthrough in Skin Cancer Treatment: Promising Results from New Therapy Breakthrough in Ethylene Oxide Production Promises Lower Costs and Reduced Emissions The Crucial Role of Health Economics and Outcomes Research in Biopharma’s Future Tulane Researchers Unveil CRISPR-Based Test for Rapid, Accurate Diagnosis of Fungal Pneumonia

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後